BIOMIRA INC

EDMONTON ALBERTA CAN, A0 How do I update this listing?

Biomira is based out of Edmonton Alberta Can. Oncothyreon Inc. researches and develops products to treat cancer; focused on core competency in immunotherapeutics. Its lead cancer vaccine candidate under clinical development is a synthetic Mucin 1 peptide vaccine, BLP25 liposome vaccine (L-BLP25). The firm has no submitted 13F filings and does not appear to be an investment advisor.

Create Alert

Contact Info

biomira inc
2011-94TH STREET
EDMONTON ALBERTA CAN A0    19899-1709

Business Phone: 7804902812
SEC SIC CODE:
2836-BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)

Recent SEC Filings

Active Schedule 13D and 13G events

Sign in to see

Insider Transactions in the past year

Loading...

Elevate your investments